Mimedx (MDXG) Tax Provisions (2013 - 2026)
Mimedx (MDXG) reported Tax Provisions of -$4.5 million for Q1 2026, down 381.37% on a YoY basis from $1.6 million in Q1 2025, and down 167.7% sequentially from $6.6 million in Q4 2025.
Mimedx (MDXG) Tax Provisions (2013 - 2026) Analysis & Trends
Mimedx (MDXG) has 14 years of Tax Provisions data on file, last reported at -$4.5 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 381.37% year-over-year to -$4.5 million; the trailing twelve-month figure through Mar 2026 stood at $11.6 million (down 20.04% YoY), and the FY2025 full-year result was $17.7 million, up 15.61% from the prior year.
- Tax Provisions slipped to -$4.5 million in Q1 2026, from $6.6 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $6.6 million in Q4 2025 to a low of -$37.4 million in Q4 2023.
- A 5-year average of -$476117.6 and a median of $591000.0 in 2023 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions tumbled 133582.14% in 2023 and jumped 7660.81% in 2024, its largest moves.
- Tracing MDXG's Tax Provisions over 5 years: stood at $28000.0 in 2022, then plunged by 133582.14% to -$37.4 million in 2023, then surged by 110.2% to $3.8 million in 2024, then surged by 73.29% to $6.6 million in 2025, then sank by 167.7% to -$4.5 million in 2026.
- Business Quant data shows MDXG's Tax Provisions at -$4.5 million in Q1 2026, $6.6 million in Q4 2025, and $6.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn | -4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.47 Mn |
| Dec 31, 2025 | 6.60 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 1.59 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.54 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | -37.38 Mn |
| Sep 30, 2023 | 591,000.00 |
| Jun 30, 2023 | -74,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 28,000.00 |
| Sep 30, 2022 | 53,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | -108,000.00 |
| Sep 30, 2021 | 301,000.00 |
| Jun 30, 2021 | -5,000.00 |